Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
Mangoceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Securities to Be Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount to Be Registered(1) | Proposed Maximum Offering Price | Proposed Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Shares of common stock, par value $0.0001 per share (Common Stock) issuable upon exercise of the Warrants | 457(c) | 1,500,000 | $ | 0.3002 | $ | 450,300 | $ | 0.00014760 | $ | 66.46 | |||||||||||||
| Equity | Shares of Common Stock issuable pursuant conversions of Series B Preferred Stock | 457(c) | 14,666,667 | $ | 0.3002 | $ | 4,402,934 | $ | 0.00014760 | $ | 649.88 | |||||||||||||
| Total Offering Amounts | 16,166,667 | $ | 4,853,234 | $ | 0.00014760 | $ | 716.34 | |||||||||||||||||
| Total Fees Previously Paid | — | — | $ | |||||||||||||||||||||
| Total Fee Offsets | — | — | — | |||||||||||||||||||||
| Net Fee Due | $ | — | — | $ | 716.34 | |||||||||||||||||||
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions. |
| (2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales price of the Common Stock as reported on Nasdaq on August 12, 2024. |